GenSight Biologics S.A. (LON:0RIM)
London
· Delayed Price · Currency is GBP · Price in EUR 0.2025
-0.0125 (-5.81%)
At close: Jun 20, 2025
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of 22.28 million as of June 26, 2025. Its market cap has decreased by -21.22% in one year.
Market Cap
22.28M
Enterprise Value
36.46M
Revenue
2.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 212.26M to 22.28M, a decrease of -89.51%. That is a compound annual growth rate of -22.25%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.21B |
| HSBC Holdings | 153.69B |
| Shell | 152.97B |
| Unilever | 113.86B |
| British American Tobacco p.l.c. | 76.98B |
| Rolls-Royce Holdings | 75.93B |
| RELX PLC | 71.58B |
| Rio Tinto Group | 71.17B |